BMO Capital Downgrades United Therapeutics Corp. (UTHR) to Market Perform
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $499.73 -0.31%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BMO Capital downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Outperform to Market Perform following CRL from FDA for Oral Treprostinil
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $53.28 yesterday.
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $53.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Downgrades Manappuram Finance Ltd (MGFL:IN) to Hold (3)
- JPMorgan Downgrades York Space Systems (YSS) to Neutral
- Lake Street Downgrades SoundThinking (SSTI) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
